Pharmaceutical Company
Bio-pharmaceutical drugs & drug development programs, particularly those designed to treat rare diseases, such as Orphan Drug Act Incentives, Medicare & Medicaid access, charitable foundations for co-pay assistance, and newborn screening. Bio-pharmaceutical drugs & drug development programs, particularly those designed to treat rare diseases, such as Orphan Drug Act Incentives, Medicare & Medicaid access, charitable foundations for co-pay assistance, and newborn screening. Bio-pharmaceutical drugs & drug development programs, particularly those designed to treat rare diseases, such as Orphan Drug Act Incentives, Medicare & Medicaid access, charitable foundations for co-pay assistance, and newborn screening. Bio-pharmaceutical drugs & drug development programs; particularly those designed to treat rare diseases, such as Orphan Drug Act Incentives, Medicare & Medicaid access, charitable foundations for co-pay assistance, and newborn screening.
HCR - Health Issues BUD - Budget/Appropriations MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CHAMBER HILL STRATEGIES
3325 N Kensington Street, Arlington, VA, 22207, US
MELISSA BARTLETT (Counsel, U.S. House of Representatives, Committee on Energy and Commerce) ANNA KATHERINE WEINSTEIN MELISSA BARTLETT (Counsel, U.S. House of Representatives, Committee on Energy and Commerce) ANNA KATHERINE WEINSTEIN MELISSA BARTLETT (Counsel, U.S. House of Representatives, Committee on Energy and Commerce) ANNA KATHERINE WEINSTEIN MELISSA BARTLETT (Counsel, U.S. House of Representatives, Committee on Energy and Commerce) ANNA KATHERINE WEINSTEIN
Counsel, U.S. House of Representatives, Committee on Energy and Commerce Counsel, U.S. House of Representatives, Committee on Energy and Commerce Counsel, U.S. House of Representatives, Committee on Energy and Commerce Counsel, U.S. House of Representatives, Committee on Energy and Commerce